Timothée Olivier, MD· @Timothee_MD · X·· 2 days agoScore90
Body
#ESMO26
NATALEE 6-y OS results are online, ahead of today's presentation (2:25 pm).
OS HR 0.809 (95% CI 0.661–0.989); 6-y OS: 91.9% vs 89.7% (Δ2.1%). Nominal 1-sided P=.019.
What remains key? 👉 Post-protocol care!
See why in my talk at @MDAnderson_ES 👇
1544 views · 19 likes · 4 reposts · 0 replies
Conference abstracts
LBA25matched by Proffered paper 1: Breast cancer, early and advanced stage
Adjuvant ribociclib (RIB) + nonsteroidal aromatase inhibitor (NSAI) in patients (pts) with HR+/HER2− early breast cancer (EBC): NATALEE 6-y overall survival (OS) and efficacy outcomes
https://esmocongress.esmo.orgSource: Timothée Olivier, MD · x.com